Alkem Laboratories Ltd (ALKEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 1000019,
    "name": "Alkem Lab",
    "stock_name": "Alkem Lab",
    "full_name": "Alkem Laboratories Ltd",
    "name_url": "stocks-analysis/alkem-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "5,500.00",
    "chg": -183,
    "chgp": "-3.22%",
    "dir": -1,
    "prev_price": "5,683.00",
    "mcapval": "68,098.00 Cr",
    "mcap": "Mid Cap",
    "scripcode": 539523,
    "symbol": "ALKEM",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "sector_id": 65,
    "indexname": "India SENSEX",
    "isin": "INE540L01014",
    "curr_date": "Aug 04, 03:30 PM",
    "curr_time": "05:15 AM",
    "last_traded_at": "Aug 04, 03:30 PM IST",
    "bse_nse_vol": "38.53 k",
    "exc_status": "Active",
    "traded_date": "Aug 04, 2026",
    "traded_date_str": "2026 08 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/alkem-lab-1000019-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4135854",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4135854.png",
        "date": "2026-08-04 08:56:14",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 3 August 2026. This shift reflects a complex interplay of deteriorating technical indicators, subdued financial trends, and cautious valuation metrics, despite the company’s strong operational efficiency and long-term market outperformance."
      },
      {
        "title": "Alkem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-ltd-sees-technical-momentum-shift-amid-mixed-signals-4135162",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_technicaldot_4135162.png",
        "date": "2026-08-04 08:08:57",
        "description": "Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators present a nuanced picture for investors navigating the current market environment."
      },
      {
        "title": "Alkem Laboratories Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/alkem-laboratories-ltd-is-rated-hold-by-marketsmojo-4131156",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/8/AlkemLaboratori_mojoScore_4131156.png",
        "date": "2026-08-01 10:10:36",
        "description": "Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 01 August 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market performance."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Signalling Potential Market Shift",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-signalling-potential-market-shift-4128906",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128906.png",
        "date": "2026-07-30 15:00:18",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, supported by robust volume and price action, prompting a reassessment of its market positioning and investor sentiment."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128856",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128856.png",
        "date": "2026-07-30 14:00:15",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price performance, combined with increased volumes and a notable rise in futures and options participation, suggests evolving investor sentiment in the pharmaceuticals and biotechnology sector."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128809",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128809.png",
        "date": "2026-07-30 13:00:14",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock, currently trading close to its 52-week high, has outperformed its sector peers amid rising volumes and shifting investor positioning."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-4128740",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128740.png",
        "date": "2026-07-30 12:00:14",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improving technical indicators, suggesting renewed investor confidence."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Surge in Derivatives Open Interest Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-surge-in-derivatives-open-interest-amid-bullish-momentum-4128666",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128666.png",
        "date": "2026-07-30 11:00:10",
        "description": "Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume and price action, as investors recalibrate their positions amid positive momentum."
      },
      {
        "title": "Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/alkem-laboratories-sees-sharp-open-interest-surge-amid-bullish-momentum-4128261",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/7/AlkemLaboratori_oi_spurts_by_underlying_4128261.png",
        "date": "2026-07-30 10:00:10",
        "description": "Alkem Laboratories Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance, coupled with rising volumes and improving technicals, suggests a growing bullish sentiment among traders and investors."
      }
    ],
    "total": 634,
    "sid": "1000019",
    "stock_news_url": "https://www.marketsmojo.com/news/alkem-laboratories-1000019"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Change in Management",
      "datetime": "03-Aug-2026",
      "details": "Please find attached herewith regarding Appointment of Senior Management Personnel.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "30-Jul-2026",
      "details": "Please find attached herewith Disclosure under Regulation 30 of the SEBI (LODR) Regulation 2015.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "30-Jul-2026",
      "details": "Please find attached herewith a copy Newspaper Publication.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "14 Aug 2026"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Alkem Laboratories Ltd has declared <strong>2150%</strong> dividend, ex-date: 20 Feb 26",
          "dt": "2026-02-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Alkem Laboratories Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-08-04 08:56:14

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell by MarketsMOJO as of 3 August 2026. This shift reflects a complex interplay of deteriorating technical indicators, subdued financial trends, and cautious valuation metrics, despite the company’s strong operational efficiency and long-term market outperformance.

Read full news article

Alkem Laboratories Ltd Sees Technical Momentum Shift Amid Mixed Signals

2026-08-04 08:08:57

Alkem Laboratories Ltd, a mid-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a sideways trend. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s price action and technical indicators present a nuanced picture for investors navigating the current market environment.

Read full news article

Alkem Laboratories Ltd is Rated Hold by MarketsMOJO

2026-08-01 10:10:36

Alkem Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 20 July 2026. While the rating change occurred on that date, the analysis and financial metrics discussed here reflect the company’s current position as of 01 August 2026, providing investors with the most up-to-date view of the stock’s fundamentals, returns, and market performance.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Signalling Potential Market Shift

2026-07-30 15:00:18

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical mid-cap stock has outperformed its sector peers, supported by robust volume and price action, prompting a reassessment of its market positioning and investor sentiment.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 14:00:15

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The stock’s recent price performance, combined with increased volumes and a notable rise in futures and options participation, suggests evolving investor sentiment in the pharmaceuticals and biotechnology sector.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 13:00:14

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical mid-cap stock, currently trading close to its 52-week high, has outperformed its sector peers amid rising volumes and shifting investor positioning.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-07-30 12:00:14

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling heightened market activity and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume patterns and improving technical indicators, suggesting renewed investor confidence.

Read full news article

Alkem Laboratories Sees Sharp Surge in Derivatives Open Interest Amid Bullish Momentum

2026-07-30 11:00:10

Alkem Laboratories Ltd has witnessed a significant surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The pharmaceutical giant’s stock has outperformed its sector peers, supported by robust volume and price action, as investors recalibrate their positions amid positive momentum.

Read full news article

Alkem Laboratories Sees Sharp Open Interest Surge Amid Bullish Momentum

2026-07-30 10:00:10

Alkem Laboratories Ltd has witnessed a notable surge in open interest in its derivatives segment, signalling increased market participation and potential directional bets. The stock’s recent outperformance, coupled with rising volumes and improving technicals, suggests a growing bullish sentiment among traders and investors.

Read full news article

View All News